Oventus Medical (ASX:OVN) EBIT : A$-10.26 Mil (TTM As of Dec. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical EBIT?

Oventus Medical's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2021 was A$-5.12 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2021 was A$-10.26 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Oventus Medical's annualized ROC % for the quarter that ended in Dec. 2021 was -210.27%. Oventus Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was -786.04%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Oventus Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was -1,105.50%.

Oventus Medical EBIT Historical Data

The historical data trend for Oventus Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical EBIT Chart

Oventus Medical Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

EBIT

-6.65

-6.15

-8.16

-10.12

-9.80

Oventus Medical Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
EBIT	Get a 7-Day Free Trial						-5.12	-5.00	-4.67	-5.14	-5.12

Competitive Comparison of Oventus Medical's EBIT

For the Medical Devices subindustry, Oventus Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oventus Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oventus Medical's EV-to-EBIT falls into.

Oventus Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-10.26 Mil.

Oventus Medical (ASX:OVN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Oventus Medical's annualized ROC % for the quarter that ended in Dec. 2021 is calculated as:

	ROC % (Q: Dec. 2021 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2021 )	+	Invested Capital (Q: Dec. 2021 ))	/ count )
=	-10.132 * ( 1 - 0% )	/	( (5.027	+	4.61)	/ 2 )
=	-10.132	/	4.8185
=	-210.27 %

where

	Invested Capital		(Q: Jun. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	15.079	-	1.664	-	( 9.157	-	max(0, 2.101	-	10.489	+	9.157	))
=	5.027

	Invested Capital		(Q: Dec. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	9.861	-	1.15	-	( 4.349	-	max(0, 1.576	-	5.677	+	4.349	))
=	4.61

Note: The Operating Income data used here is two times the semi-annual (Dec. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

Oventus Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2021 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2021		Q: Dec. 2021
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-10.246	/	( ( (1.404 + max(-0.603, 0))	+	(1.203 + max(-0.045, 0)) )	/	2 )
=	-10.246	/	( ( 1.404	+	1.203 )	/	2 )
=	-10.246	/	1.3035
=	-786.04 %

where Working Capital is:

	Working Capital		(Q: Jun. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.155	+	0.104	+	1.02)	-	(1.664	+	0	+	0.218)
=	-0.603

	Working Capital		(Q: Dec. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.175	+	0.127	+	1.026)	-	(1.15	+	0	+	0.223)
=	-0.045

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Oventus Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2021 )
	=	-10.259	/	0.928
	=	-1,105.50 %

Oventus Medical EBIT Related Terms

Thank you for viewing the detailed overview of Oventus Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Oventus Medical (ASX:OVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068

Website

https://www.o2vent.com

Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines